For example, our group showed that nitrogen-containing bisphosphonates can directly inhibit the growth of EGFR-driven cancer cells, making it possible to potentially repurpose them to treat lung, breast, gastrointestinal, head and neck, and other cancers (Stachnik et al., 2014; Yuen et al., 2014). The gene discussed is EGFR; the disease is cancer.